Key result
Administration of the ACE inhibitor enalaprilat and the AT1 receptor antagonist candesartan did not affect the hypoxic pulmonary vasoconstriction response in anaesthetized dogs.
Why the study?
Does angiotensin-converting enzyme inhibition or type 1 angiotensin II receptor blockade inhibit hypoxic pulmonary vasoconstriction in anaesthetized dogs?
Does angiotensin-converting enzyme inhibition or type 1 angiotensin II receptor blockade inhibit hypoxic pulmonary vasoconstriction in anaesthetized dogs?
Answers are grounded in this paper and cite their sources.
Endogenous angiotensin II does not appear to mediate acute hypoxic pulmonary vasoconstriction in intact dogs, suggesting that ACE inhibitors or ARBs may not worsen gas exchange by inhibiting this mechanism in critically ill patients.
INTRODUCTION: The role played by several vasoactive mediators that are synthesized and released by the pulmonary vascular endothelium in the regulation of hypoxic pulmonary vasoconstriction (HPV) remains unclear. As a potent vasoconstrictor, angiotensin II could be involved. We tested the hypothesis that angiotensin-converting enzyme inhibition by enalaprilat and type 1 angiotensin II receptor blockade by candesartan would inhibit HPV. METHODS: HPV was evaluated in anaesthetized dogs, with an intact pulmonary circulation, by examining the increase in the Ppa-Ppao gradient (mean pulmonary artery pressure minus occluded pulmonary artery pressure) that occurred in response to hypoxia (inspiratory oxygen fraction of 0.1) at constant pulmonary blood flow. Plasma renin activity and angiotensin II immunoreactivity were measured to determine whether activation or inhibition of the renin-angiotensin system was present. RESULTS: Administration of enalaprilat and candesartan did not affect the Ppa-Ppao gradient at baseline or during hypoxia. Plasma renin activity and angiotensin II immunoreactivity increased during hypoxia, and subsequent measurements were consistent with effective angiotensin-converting enzyme inhibition after administration of enalaprilat, and with angiotensin receptor blockade after administration of candesartan. CONCLUSION: These results suggest that, although the renin-angiotensin system was activated in hypoxia, angiotensin II is not normally involved in mediating acute HPV.
No takes yet. Share an insight, caveat, or question.
Hubloue et al. (2004) studied Hypoxic pulmonary vasoconstriction (n=16). Enalaprilat and Candesartan vs. Baseline (pre-drug administration) was evaluated on Increase in Ppa-Ppao gradient (mean pulmonary artery pressure minus occluded pulmonary artery pressure) in response to hypoxia. Administration of the ACE inhibitor enalaprilat and the AT1 receptor antagonist candesartan did not affect the hypoxic pulmonary vasoconstriction response in anaesthetized dogs.
Synapse has enriched 10 related papers. Consider them for comparative context: